Article Text

Download PDFPDF
Unremitting sympathetic ophthalmia associated with homozygous interleukin-10-1082A single nucleotide polymorphism
  1. N Glover1,
  2. J J Ah-Chan1,
  3. P Frith1,
  4. S Downes1,
  5. D Atan2
  1. 1
    Oxford Eye Hospital, Radcliffe Infirmary, Oxford, UK
  2. 2
    Bristol Eye Hospital, Bristol, UK
  1. J J Ah-Chan, Oxford Eye Hospital, The John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK; johnvic2005{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sympathetic ophthalmia (SO) is a rare,1 bilateral, granulatomatous panuveitis following injury to one eye. Inflammation develops after the relative immune privilege of the eye is compromised, causing sensitisation to previously sequestrated uveoretinal antigens.2 Although potentially blinding, the outcome may be favourable if aggressive systemic immunosuppression is initiated early.1 3

While certain genetic variants of the human leucocyte antigen (HLA) genes influence susceptibility to SO,4 5 single nucleotide polymorphisms (SNPs) in cytokine genes influence severity of disease.7 We report a case of SO who progressively deteriorated despite early immunosuppression. She was later found to be homozygous for the interleukin-10 (IL-10)-1082A SNP.

Case report

A 48-year-old woman presented with a 2-week history of blurred vision and floaters in her left eye, 9 weeks after a right ruptured globe repair. …

View Full Text


  • Funding: None.

  • Competing interests: None.